Srikala S Sridhar
The Contemporary Use of Radium-223 in Metastatic Castration-resistant Prostate Cancer
Heinrich D, van Oort I, Tucci M, Sridhar S, Omlin A, Olmos D, Kramer G, Kindblom J, Keizman D, Daugaard G, Chi K, Cathomas R, Caffo O, Bergman A, Bektic J, Nilsson S. The Contemporary Use of Radium-223 in Metastatic Castration-resistant Prostate Cancer. Clin Genitourin Cancer 2017
Sep 6, 2017The Contemporary Use of Radium-223 in Metastatic Castration-resistant Prostate Cancer
Sep 6, 2017Clin Genitourin Cancer 2017
Heinrich Daniel, van Oort Inge, Tucci Marcello, Sridhar Srikala S, Omlin Aurelius, Olmos David, Kramer Gero, Kindblom Jon, Keizman Daniel, Daugaard Gedske, Chi Kim N, Cathomas Richard, Caffo Orazio, Bergman Andries M, Bektic Jasmin, Nilsson Sten
Efficacy and toxicity of abiraterone and docetaxel in octogenarians with metastatic castration-resistant prostate cancer
Leibowitz-Amit R, Templeton A, Alibhai S, Knox J, Sridhar S, Tannock I, Joshua A. Efficacy and toxicity of abiraterone and docetaxel in octogenarians with metastatic castration-resistant prostate cancer. J Geriatr Oncol 2014; 6:23-8.
Oct 7, 2014Efficacy and toxicity of abiraterone and docetaxel in octogenarians with metastatic castration-resistant prostate cancer
Oct 7, 2014J Geriatr Oncol 2014; 6:23-8
Leibowitz-Amit Raya, Templeton Arnoud, Alibhai Shabbir M, Knox Jennifer J, Sridhar Srikala S, Tannock Ian F, Joshua Anthony M
Retreatment of men with metastatic castrate-resistant prostate cancer with abiraterone
Leibowitz-Amit R, Alimohamed N, Vera-Badillo F, Seah J, Templeton A, Knox J, Tannock I, Sridhar S, Joshua A. Retreatment of men with metastatic castrate-resistant prostate cancer with abiraterone. Prostate 2014; 74:1462-4.
Aug 11, 2014Retreatment of men with metastatic castrate-resistant prostate cancer with abiraterone
Aug 11, 2014Prostate 2014; 74:1462-4
Leibowitz-Amit Raya, Alimohamed Nimira, Vera-Badillo Francisco E, Seah Jo-An, Templeton Arnoud, Knox Jennifer J, Tannock Ian F, Sridhar Srikala S, Joshua Anthony M
Abiraterone acetate in metastatic castration-resistant prostate cancer: a retrospective review of the Princess Margaret experience of (I) low dose abiraterone and (II) prior ketoconazole
Leibowitz-Amit R, Sridhar S, Tannock I, Knox J, Alimohamed N, Vera-Badillo F, Templeton A, Atenafu E, Seah J, Joshua A. Abiraterone acetate in metastatic castration-resistant prostate cancer: a retrospective review of the Princess Margaret experience of (I) low dose abiraterone and (II) prior ketoconazole. Eur J Cancer 2014; 50:2399-407.
Jul 16, 2014Abiraterone acetate in metastatic castration-resistant prostate cancer: a retrospective review of the Princess Margaret experience of (I) low dose abiraterone and (II) prior ketoconazole
Jul 16, 2014Eur J Cancer 2014; 50:2399-407
Leibowitz-Amit Raya, Sridhar Srikala S, Tannock Ian F, Knox Jennifer J, Alimohamed Nimira, Vera-Badillo Francisco E, Templeton Arnoud, Atenafu Eshetu G, Seah Jo-An, Joshua Anthony M